1. Home
  2. BRTX
  3. BRTX News

Latest BioRestorative Therapies Inc. (NV) (BRTX) News on August 31, 2025

BRTX

GuruFocus.com

18 days ago

BioRestorative Therapies Inc (BRTX) Q2 2025 Earnings Call Highlights: Revenue Surge Amid ...

Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates
BRTX

Zacks

18 days ago

Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates

BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
BRTX

GlobeNewswire

18 days ago

BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
BRTX

GlobeNewswire

2 months ago

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates

BioRestorative Announces Share Repurchase Program
BRTX

GlobeNewswire

2 months ago

BioRestorative Announces Share Repurchase Program

BRTX

MT Newswires

3 months ago

BioRestorative Therapies Says BRTX-100 Improved Function in Phase 2 Chronic Lumbar Disc Disease Trial

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
BRTX

GlobeNewswire

3 months ago

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
BRTX

GlobeNewswire

3 months ago

BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
BRTX

GlobeNewswire

3 months ago

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025

7 Summer Side Hustles That Can Pay $1,000 a Week or More
BRTX

GOBankingRates

3 months ago

7 Summer Side Hustles That Can Pay $1,000 a Week or More

Will Tesla have to play catch up to Waymo's robotaxis?
BRTX

Yahoo Finance Video

3 months ago

Will Tesla have to play catch up to Waymo's robotaxis?

Why Scott Bessent wants to make it easier for banks to own Treasurys
BRTX

Yahoo Finance

3 months ago

Why Scott Bessent wants to make it easier for banks to own Treasurys

When are people too old to do their jobs?
BRTX

The Guardian

3 months ago

When are people too old to do their jobs?

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry
BRTX

GlobeNewswire

3 months ago

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

BRTX

GlobeNewswire

3 months ago

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
BRTX

PR Newswire

3 months ago

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

Statement by Minister Guilbeault on Portuguese Heritage Month
BRTX

CNW Group

3 months ago

Statement by Minister Guilbeault on Portuguese Heritage Month

BRTX

Thomson Reuters StreetEvents

4 months ago

Q1 2025 BioRestorative Therapies Inc Earnings Call

BRTX

GuruFocus.com

4 months ago

BioRestorative Therapies Inc (BRTX) Q1 2025 Earnings Call Highlights: Navigating Challenges ...

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates
BRTX

Zacks

4 months ago

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
BRTX

GlobeNewswire

4 months ago

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
BRTX

GlobeNewswire

4 months ago

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
BRTX

GlobeNewswire

4 months ago

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025

BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025
BRTX

GlobeNewswire

4 months ago

BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
BRTX

GlobeNewswire

4 months ago

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States
BRTX

GlobeNewswire

5 months ago

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States

BioRestorative Therapies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
BRTX

Simply Wall St.

5 months ago

BioRestorative Therapies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
BRTX

GlobeNewswire

5 months ago

BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update

BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
BRTX

GlobeNewswire

5 months ago

BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025

BRTX

MT Newswires

6 months ago

BioRestorative Therapies Says FDA Clears BRTX-100 Trial in Chronic Cervical Discogenic Pain

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
BRTX

GlobeNewswire

6 months ago

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update
BRTX

GlobeNewswire

6 months ago

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline
BRTX

GlobeNewswire

6 months ago

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
BRTX

GlobeNewswire

6 months ago

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program

BRTX-100 Front and Center at ORS 2025
BRTX

GlobeNewswire

7 months ago

BRTX-100 Front and Center at ORS 2025

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Shift From Loss To Profit
BRTX

Simply Wall St.

7 months ago

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Shift From Loss To Profit

Pleasing Signs As A Number Of Insiders Buy BioRestorative Therapies Stock
BRTX

Simply Wall St.

8 months ago

Pleasing Signs As A Number Of Insiders Buy BioRestorative Therapies Stock

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program
BRTX

GlobeNewswire

9 months ago

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program

BioRestorative Therapies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
BRTX

Simply Wall St.

9 months ago

BioRestorative Therapies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
BRTX

GlobeNewswire

10 months ago

BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
BRTX

GlobeNewswire

10 months ago

BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
BRTX

GlobeNewswire

10 months ago

BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium

BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
BRTX

GlobeNewswire

10 months ago

BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health

BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
BRTX

GlobeNewswire

10 months ago

BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program

BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events

BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs

Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates
BRTX

Zacks

a year ago

Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates

BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update

BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024

BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine

BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program

BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results

BRTX

MT Newswires

a year ago

Top Midday Gainers

BRTX

MT Newswires

a year ago

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

BRTX

MT Newswires

a year ago

Sector Update: Health Care

BRTX

MT Newswires

a year ago

BioRestorative Therapies in Licensing Talks for Metabolic Disease Program -- Shares Rise Pre-Bell

BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates
BRTX

Zacks

a year ago

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates

BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference

BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice

BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market
BRTX

ACCESSWIRE

a year ago

BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market

BioRestorative Therapies Provides First Quarter 2024 Business Update
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Provides First Quarter 2024 Business Update

BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity

BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

10 Micro-Cap Healthcare Stocks Insiders Are Buying
BRTX

Insider Monkey

a year ago

10 Micro-Cap Healthcare Stocks Insiders Are Buying

BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease

BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants

BioRestorative Therapies Full Year 2023 Earnings: Beats Expectations
BRTX

Simply Wall St.

a year ago

BioRestorative Therapies Full Year 2023 Earnings: Beats Expectations

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K

BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
BRTX

GlobeNewswire

a year ago

BioRestorative Therapies to Participate in the 36th Annual ROTH Conference

Favourable Signals For BioRestorative Therapies: Numerous Insiders Acquired Stock
BRTX

Simply Wall St.

2 years ago

Favourable Signals For BioRestorative Therapies: Numerous Insiders Acquired Stock

BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting
BRTX

ACCESSWIRE

2 years ago

BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting

BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
BRTX

GlobeNewswire

2 years ago

BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market

BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
BRTX

GlobeNewswire

2 years ago

BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
BRTX

GlobeNewswire

2 years ago

BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting

Natural Health Trends to Report Fourth Quarter 2023 Financial Results on February 7th
BRTX

GlobeNewswire

2 years ago

Natural Health Trends to Report Fourth Quarter 2023 Financial Results on February 7th

GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER
BRTX

CNW Group

2 years ago

GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER

When Will Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Become Profitable?
BRTX

Simply Wall St.

2 years ago

When Will Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Become Profitable?

Worksport Announces SOLIS Solar Truck Cover will be Available for FORD, RAM (Stellantis) & GM
BRTX

GlobeNewswire

2 years ago

Worksport Announces SOLIS Solar Truck Cover will be Available for FORD, RAM (Stellantis) & GM

EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
BRTX

GlobeNewswire

2 years ago

EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

Bluerock Homes Trust (BHM) Announces First Quarter Dividends on Series A Preferred Stock
BRTX

PR Newswire

2 years ago

Bluerock Homes Trust (BHM) Announces First Quarter Dividends on Series A Preferred Stock

Marti Announces Completion of Redemption of Outstanding Warrants
BRTX

Business Wire

2 years ago

Marti Announces Completion of Redemption of Outstanding Warrants

Space Race Stocks: 3 Companies Shooting for the Stars
BRTX

InvestorPlace

2 years ago

Space Race Stocks: 3 Companies Shooting for the Stars

Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK
BRTX

GlobeNewswire

2 years ago

Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK

BRTX

Business Wire

2 years ago

MFS Announces Closed-End Fund Distributions

BRTX

Business Wire

2 years ago

MariaDB Files Form 10-K Annual Report

ReTo Eco-Solutions, Inc. Announces First Half 2023 Financial Results
BRTX

PR Newswire

2 years ago

ReTo Eco-Solutions, Inc. Announces First Half 2023 Financial Results

ASHFORD SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES
BRTX

PR Newswire

2 years ago

ASHFORD SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES

BRTX

Business Wire

2 years ago

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

Hain Celestial Group Announces Amber Jefferson as New Chief People Officer
BRTX

PR Newswire

2 years ago

Hain Celestial Group Announces Amber Jefferson as New Chief People Officer

Royalty Management Holding Corporation’s and American Resources Corporation’s Investment In Advanced Magnetic Labs, Inc. Results in Commercial Manufacturing of Permanent Magnets
BRTX

ACCESSWIRE

2 years ago

Royalty Management Holding Corporation’s and American Resources Corporation’s Investment In Advanced Magnetic Labs, Inc. Results in Commercial Manufacturing of Permanent Magnets

Investors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push Stock Down 27%
BRTX

Simply Wall St.

2 years ago

Investors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push Stock Down 27%

BRTX

Market Exclusive

2 years ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

BRTX

Business Wire

2 years ago

MOGU Announces Unaudited Financial Results for the Six Months Ended September 30, 2023

iClick Interactive Asia Group First Half 2023 Earnings: US$2.92 loss per share (vs US$5.37 loss in 1H 2022)
BRTX

Simply Wall St.

2 years ago

iClick Interactive Asia Group First Half 2023 Earnings: US$2.92 loss per share (vs US$5.37 loss in 1H 2022)

Bears are Losing Control Over Gain Therapeutics, Inc. (GANX), Here's Why It's a 'Buy' Now
BRTX

Zacks

2 years ago

Bears are Losing Control Over Gain Therapeutics, Inc. (GANX), Here's Why It's a 'Buy' Now

MariaDB Finalizes Spinoff of SkySQL
BRTX

Business Wire

2 years ago

MariaDB Finalizes Spinoff of SkySQL

Share on Social Networks: